Pages that link to "Q41463095"
Jump to navigation
Jump to search
The following pages link to The natriuretic-peptide family (Q41463095):
Displaying 50 items.
- Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme (Q22254421) (← links)
- Furin-mediated Processing of Pro-C-type Natriuretic Peptide (Q28203022) (← links)
- Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data (Q31131772) (← links)
- Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases. (Q31940132) (← links)
- Current and novel pharmacologic approaches in advanced heart failure (Q33688965) (← links)
- Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators (Q33777106) (← links)
- Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence (Q33862358) (← links)
- Effect of thermal therapy using hot water bottles on brain natriuretic Peptide in chronic hemodialysis patients (Q33936148) (← links)
- Plasma brain natriuretic peptide levels in normotensive Type 2 diabetic patients without cardiac disease and macroalbuminuria (Q34128749) (← links)
- Genomic structures of the human and murine corin genes and functional GATA elements in their promoters (Q34142432) (← links)
- New epidemiologic perspectives concerning mild-to-moderate heart failure (Q34239859) (← links)
- Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin (Q34269987) (← links)
- Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide (Q34326399) (← links)
- The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure (Q34346282) (← links)
- The hypothalamus and hypertension (Q34388100) (← links)
- Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review (Q34495751) (← links)
- Vasopeptidase inhibitors and their potential role in diabetes (Q34592323) (← links)
- Vascular relaxation induced by C-type natriuretic peptide involves the ca2+/NO-synthase/NO pathway. (Q35161211) (← links)
- Altered Regulation of Renal Nitric Oxide and Atrial Natriuretic Peptide Systems in Lipopolysaccharide-induced Kidney Injury (Q35569352) (← links)
- BNP as discharge criteria for heart failure (Q35570395) (← links)
- Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure (Q35772664) (← links)
- Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: an 8-year follow-up of the Hoorn Study (Q36426776) (← links)
- Screening for ventricular remodeling (Q36473364) (← links)
- An approach to achieve long-term expression in skin gene therapy (Q37109093) (← links)
- A review on B-type natriuretic peptide monitoring: assays and biosensors (Q37171880) (← links)
- Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide (Q37343367) (← links)
- Changes of atrial natriuretic Peptide system in rats with puromycin aminonucleoside-induced nephrotic syndrome (Q37398411) (← links)
- Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure (Q37477161) (← links)
- N-TproBNP as biomarker in systemic sclerosis. (Q38016375) (← links)
- Neprilysin inhibition in chronic kidney disease (Q38241522) (← links)
- Ularitide: a natriuretic peptide candidate for the treatment of acutely decompensated heart failure (Q38567657) (← links)
- Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies (Q38709338) (← links)
- Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure (Q38871148) (← links)
- The atrial natriuretic peptide receptor (NPR-A/GC-A) is dephosphorylated by distinct microcystin-sensitive and magnesium-dependent protein phosphatases (Q40753432) (← links)
- Efficacy and safety of electroacupuncture in acute decompensated heart failure: a study protocol for a randomized, patient- and assessor-blinded, sham controlled trial (Q40978104) (← links)
- Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction (Q41265902) (← links)
- Hyponatraemia in cases of children with pneumonia (Q41413939) (← links)
- Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis (Q42707998) (← links)
- Improving risk stratification in heart failure: a role for new biomarkers? (Q43119693) (← links)
- L-NAME enhances responses to atrial natriuretic peptide in the pulmonary vascular bed of the cat. (Q43610728) (← links)
- Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations (Q44114976) (← links)
- Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure (Q44123394) (← links)
- Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion (Q44489655) (← links)
- The albuminuric action of atrial natriuretic peptide is not modified by ACE-inhibition with perindopril in Type 2 diabetes (Q44553373) (← links)
- Differential Effects of Atrial Natriuretic Peptide on the Brain Water and Sodium after Experimental Cortical Contusion in the Rat (Q44897949) (← links)
- Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium (Q44932390) (← links)
- Comparative effect of carperitide and furosemide on left atrial pressure in dogs with experimentally induced mitral valve regurgitation (Q46230542) (← links)
- Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis (Q46921395) (← links)
- LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD. (Q47661129) (← links)
- Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation (Q48181712) (← links)